BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies
BioNTech has reported a new technology that could overcome some of the most challenging issues…
Messenger RNA (mRNA) technology is based on the idea that human cells can be used as on-demand factories to develop therapeutic proteins by giving them instructions in the form of mRNA. Although mRNA therapeutics and vaccines could be found in drug development pipelines before Covid-19 emerged, the pandemic suddenly moved the mRNA technology into the limelight.
Now, the world has seen mass vaccinations using mRNA-based vaccines developed by Moderna and Pfizer/BioNTech. But the mRNA technology holds promise for other indications as well, including cancer and rare diseases. Read on to learn how this new technology is moving into the mainstream with an influx of investments and new discoveries.
European Biotech Industry Report 2021
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations.
Go to ReportBioNTech has reported a new technology that could overcome some of the most challenging issues…
The young field of mRNA therapeutics is booming and generating huge expectations. Which are the main players…
Shire has sold its RNA therapy program to a smaller biotech that wants to accelerate…
New year, new list: here are the 10 hottest Biotech companies I will watch closely…
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a…
From the hottest research areas to the most popular city for biotech, which biotech articles have…
CureVac has raised an additional €27M ($29.5M) that will help the company keep on its…
BioNTech has turned up the heat in the race to bring an mRNA immunotherapy for…
Moderna is taking Biotech investing to new heights, as it has now increased total fundraising&partnership…
The collaboration between AstraZeneca and the money-magnet Moderna is giving its first steps. AstraZeneca is…
Update (05/07/2017): BioNTech has published new results in Nature revealing a strong immune response in all…
BioNTech is joining its mRNA technology with Bayer's expertise in veterinary applications in a new…